Fundz

Precision Neuroscience reported raising $250 Million in an initial SEC Form D filing

PRIVATESep 24, 2026

Amount Raised

$250 Million

$250 Million sold, per SEC Form D (first sale Sep 11, 2026)
$250 Million per company press release (Oct 9, 2026)

Round Type

Series D

New YorkHealth Care

Investors

Ackman Oxman InstituteMubadala CapitalB CapitalDuquesne Family OfficeMirae Asset CapitalInvusARK InvestKorea Investment PartnersHitachi VenturesJsl Health CapitalPershing Square Inc.

Description

Precision Neuroscience Corporation has announced the successful closure of a $250 million Series D financing round. The funding was co-led by Pershing Square Inc. and the Ackman Oxman Institute, reflecting the strong interest in brain-computer interface technology. The company has raised a total of $430 million since its inception in 2021

Who else raised in Health Care around the same time

Companies in the same sectors as Precision Neuroscience that raised within 45 days of this round, from Fundz verified event records.

  • Siggy raised $6M (Pre-Seed) on November 6, 2026.
  • Health In Tech raised $2.9M (Pre-Series A) on November 6, 2026.
  • BioVie raised $4.7M (Post-IPO Equity) on November 6, 2026.
  • Granit raised $6M (Seed) on November 5, 2026.
  • ArrayPatch raised $3.6M (Seed) on November 5, 2026.
  • Alethio raised $90M (Series A) on November 5, 2026.

Who to call at Precision Neuroscience, and when

A new round usually means Precision Neuroscience is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Precision Neuroscience raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Precision Neuroscience, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Precision Neuroscience. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Precision Neuroscience

Location

54 W. 21st St.

New York, New York, United States

About

Precision Neuroscience is working to provide breakthrough treatments for the millions of people worldwide suffering from neurological illnesses. The company is building the only brain–computer interface designed to be minimally invasive, safely removable, and capable of processing large amounts of data.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Precision Neuroscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsBenjamin R., Director, Executive Officer hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Precision Neuroscience's next move

See what Strategic adds

Precision Neuroscience raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.